Jenburkt Pharmaceuticals Limited (BOM:524731)
India · Delayed Price · Currency is INR 999.95
+1.95 (0.20%)
At close: Mar 4, 2026
Jenburkt Pharmaceuticals Market Cap
Jenburkt Pharmaceuticals has a market cap or net worth of 4.41 billion as of March 5, 2026. Its market cap has decreased by -6.53% in one year.
Market Cap
4.41B
Enterprise Value
4.33B
Revenue
1.65B
Ranking
n/a
PE Ratio
13.61
Stock Price
999.95
Market Cap Chart
Since November 21, 2001, Jenburkt Pharmaceuticals's market cap has increased from 33.01M to 4.41B, an increase of 13,268.90%. That is a compound annual growth rate of 22.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 4.41B | -8.24% |
| Dec 31, 2025 | 4.81B | -10.28% |
| Dec 31, 2024 | 5.36B | 78.59% |
| Dec 29, 2023 | 3.00B | 1.25% |
| Dec 30, 2022 | 2.96B | 21.19% |
| Dec 31, 2021 | 2.45B | 24.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sudarshan Pharma Industries | 6.75B |
| Kopran | 6.35B |
| Kilitch Drugs (India) | 5.67B |
| Albert David | 3.92B |
| Medicamen Biotech | 3.78B |
| Medico Remedies | 3.77B |
| Everest Organics | 3.52B |
| Amanta Healthcare | 3.44B |